Hiroki Ito

4.0k total citations
190 papers, 2.9k citations indexed

About

Hiroki Ito is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Urology. According to data from OpenAlex, Hiroki Ito has authored 190 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 85 papers in Pulmonary and Respiratory Medicine, 44 papers in Surgery and 43 papers in Urology. Recurrent topics in Hiroki Ito's work include Kidney Stones and Urolithiasis Treatments (45 papers), Urinary Bladder and Prostate Research (38 papers) and Pediatric Urology and Nephrology Studies (38 papers). Hiroki Ito is often cited by papers focused on Kidney Stones and Urolithiasis Treatments (45 papers), Urinary Bladder and Prostate Research (38 papers) and Pediatric Urology and Nephrology Studies (38 papers). Hiroki Ito collaborates with scholars based in Japan, United States and United Kingdom. Hiroki Ito's co-authors include Takashi Kawahara, Junichi Matsuzaki, Hideyuki Terao, Masahiro Yao, Yoshinobu Kubota, Hiroji Uemura, Takehiko Ogawa, Kazuhide Makiyama, H. Hattori and Hisahiro Yoshida and has published in prestigious journals such as Circulation, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Hiroki Ito

178 papers receiving 2.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hiroki Ito Japan 28 1.1k 617 517 442 438 190 2.9k
Akihiro Kawauchi Japan 33 925 0.8× 409 0.7× 710 1.4× 1.1k 2.5× 1.3k 3.0× 261 4.0k
Diane Felsen United States 34 637 0.6× 250 0.4× 516 1.0× 928 2.1× 521 1.2× 112 3.2k
Robert H. Whitaker United Kingdom 26 576 0.5× 988 1.6× 629 1.2× 320 0.7× 1000 2.3× 117 2.2k
Haim Matzkin Israel 35 1.3k 1.2× 265 0.4× 676 1.3× 484 1.1× 1.1k 2.4× 169 3.6k
U. Engelmann Germany 33 679 0.6× 164 0.3× 1.5k 2.9× 716 1.6× 1.8k 4.1× 209 4.8k
Hitoo Nakano Japan 38 613 0.6× 901 1.5× 722 1.4× 1.0k 2.3× 63 0.1× 205 4.6k
Joseph M. Gertner United States 40 451 0.4× 539 0.9× 485 0.9× 1.2k 2.8× 39 0.1× 111 4.5k
Göran Granérus Sweden 26 463 0.4× 363 0.6× 341 0.7× 480 1.1× 143 0.3× 137 2.7k
Martina Deibl Austria 25 264 0.2× 180 0.3× 416 0.8× 195 0.4× 428 1.0× 57 1.8k
John P. Hayslett United States 46 1.6k 1.4× 834 1.4× 507 1.0× 2.1k 4.7× 94 0.2× 154 5.8k

Countries citing papers authored by Hiroki Ito

Since Specialization
Citations

This map shows the geographic impact of Hiroki Ito's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hiroki Ito with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hiroki Ito more than expected).

Fields of papers citing papers by Hiroki Ito

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hiroki Ito. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hiroki Ito. The network helps show where Hiroki Ito may publish in the future.

Co-authorship network of co-authors of Hiroki Ito

This figure shows the co-authorship network connecting the top 25 collaborators of Hiroki Ito. A scholar is included among the top collaborators of Hiroki Ito based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hiroki Ito. Hiroki Ito is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ito, Yusuke, Hiroki Ito, Takashi Kawahara, et al.. (2025). Comparative real-world study of apalutamide and darolutamide in Japanese patients with non-metastatic castration-resistant prostate cancer. BMC Urology. 25(1). 235–235.
2.
Ito, Hiroki, Tetsuo Fukuda, Fukashi Yamamichi, et al.. (2025). Infectious Complications Following Mini‐Endoscopic Combined Intrarenal Surgery at Japanese Tertiary Institutions. International Journal of Urology. 32(6). 703–709.
3.
Ito, Hiroki & Y. Hirano. (2024). Long-term clinical course of two rare cases of synovitis-acne-pustulosis-hyperostosis-osteomyelitis syndrome involving only unilateral femur. Modern Rheumatology Case Reports. 8(2). 373–377. 1 indexed citations
4.
Ito, Hiroki, et al.. (2023). Clinical Factors to Predict Difficult Ureter during Ureteroscopic Lithotripsy. SHILAP Revista de lepidopterología. 2023. 1–5. 3 indexed citations
5.
Tatenuma, Tomoyuki, Hiroki Ito, Mitsuru Komeya, et al.. (2023). COMPARING LAPAROSCOPIC AND ROBOT-ASSISTED PYELOPLASTY FOR URETERO-PELVIC JUNCTION OBSTRUCTION: INITIAL EXPERIENCE FROM A SINGLE CENTER. The Japanese Journal of Urology. 114(1). 1–7.
6.
Kawahara, Takashi, et al.. (2023). Lower urinary tract symptoms are elevated with depression in Japanese women. LUTS Lower Urinary Tract Symptoms. 15(4). 116–121. 6 indexed citations
7.
Ito, Hiroki, et al.. (2023). Predictive factors for the success of trial without catheter for men with urinary retention. LUTS Lower Urinary Tract Symptoms. 15(5). 173–179. 1 indexed citations
8.
Ito, Hiroki, et al.. (2022). Predictive factors for the success of trial catheter removal for women with urinary retention. LUTS Lower Urinary Tract Symptoms. 15(1). 4–10. 1 indexed citations
9.
10.
Nakane, Keita, Takashi Ishida, Hiroki Ito, et al.. (2022). The Impact of Neutrophil-to-Lymphocyte Ratio after Two Courses of Pembrolizumab for Oncological Outcomes in Patients with Metastatic Urothelial Carcinoma. Biomedicines. 10(7). 1609–1609. 11 indexed citations
11.
Ito, Hiroki, et al.. (2022). Retrospective analysis of second-generation bipolar transurethral vaporization of the prostate in older patients aged ≥80 years with benign prostate enlargement. SHILAP Revista de lepidopterología. 2. 100034–100034. 2 indexed citations
12.
13.
Iinuma, Koji, Koji Kameyama, Kei Kawada, et al.. (2021). Efficacy and Safety of Nivolumab and Ipilimumab for Advanced or Metastatic Renal Cell Carcinoma: A Multicenter Retrospective Cohort Study. Current Oncology. 28(2). 1402–1411. 15 indexed citations
14.
Ito, Hiroki, Anna C. Sales, Marcus J. Drake, & Anthony E. Pickering. (2020). Novel model of micturition based on a multi-unit recordings of optogenetically-identified Barrington’s CRH neurons in mice. European Urology Open Science. 19. e679–e679. 1 indexed citations
15.
Kamei, Jun, Hiroki Ito, Naoki Aizawa, et al.. (2018). Age-related changes in function and gene expression of the male and female mouse bladder. Scientific Reports. 8(1). 2089–2089. 23 indexed citations
16.
Ito, Hiroki, Marcus J. Drake, Christopher Fry, Anthony Kanai, & Anthony E. Pickering. (2018). Characterization of mouse neuro‐urological dynamics in a novel decerebrate arterially perfused mouse (DAPM) preparation. Neurourology and Urodynamics. 37(4). 1302–1312. 8 indexed citations
17.
Kuroda, Shinnosuke, Hiroki Ito, Kentaro Sakamaki, et al.. (2018). A new prediction model for operative time of flexible ureteroscopy with lithotripsy for the treatment of renal stones. PLoS ONE. 13(2). e0192597–e0192597. 26 indexed citations
18.
Takahashi, A, et al.. (2005). 安定心不全患者における 123 I-MIBG心筋シンチグラフィー及びBNPの早期ウォッシュアウト率の組合せの診断価値. Circulation. 69. 209. 1 indexed citations
19.
Ito, Hiroki, et al.. (1991). [Diet and health behavior in Danish children aged 11-15 years].. PubMed. 153(14). 984–8. 8 indexed citations
20.
Clapham, David E., et al.. (1990). A comparison of the roles of purified G protein subunits in the activation of the cardiac muscarinic K+ channel.. PubMed. 45. 29–41. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Akihiro Kawauchi Breakdown of academic impact, for papers by Diane Felsen Breakdown of academic impact, for papers by Robert H. Whitaker Breakdown of academic impact, for papers by Haim Matzkin Breakdown of academic impact, for papers by U. Engelmann Breakdown of academic impact, for papers by Hitoo Nakano Breakdown of academic impact, for papers by Joseph M. Gertner Breakdown of academic impact, for papers by Göran Granérus Breakdown of academic impact, for papers by Martina Deibl Breakdown of academic impact, for papers by John P. Hayslett
Rankless by CCL
2026